Results

Total Results: 3,120 records

Showing results for "drug".

101. Final Progress Report: Improving Medication Safety Across Clinical Settings (pdf file)
     www.ahrq.gov/sites/default/files/2024-01/bates-report.pdf
     January 01, 2024 - Forty (70%) of the preventable ADEs were related to parent drug administration. … Keynote speaker, AMIA 2002 Spring Congress “A Drug by any Other Name: The Role of Informatics from Drug … Bates DW, Cullen D, Laird N, et al: Incidence of adverse drug events and potential adverse drug events … Adverse drug events in ambulatory care. … Bates DW, Cullen D, Laird N, et al: Incidence of adverse drug events and potential adverse drug

102. Final Report: Using Risk Models To Improve Safety With Dispensing High-Alert Medications in Community Pharmacies (pdf file)
     www.ahrq.gov/sites/default/files/2024-01/cohen-report.pdf
     January 01, 2024 - Scope and Significance Preventable Adverse Drug Events in Community Pharmacies Adverse drug events (ADEs … Fentanyl patch is classified by the Drug Enforcement Agency (DEA) as a Class II drug and, as such, requires … Incidence of adverse drug events and potential adverse drug events. Implications for prevention. … Serious adverse drug events reported to the Food and Drug Administration, 1998-2005. … Review of the Food and Drug Administration handling of adverse drug event reports.

103. Event Investigation and Analysis Guide: Appendix A | Agency for Healthcare Research and Quality
     www.ahrq.gov/patient-safety/capacity/candor/modules/guide4/apa.html
     February 01, 2017 - When the drug was brought into the facility, it was a different concentration from what had been used … There has been a drug shortage of the concentration that we typically use, and we had no choice but to … Our computer system is not connected to the National Drug Database, so we can’t simply scan the bottle … We have to enter every drug into our database manually. … In this case, the drug was entered as the wrong concentration.

104. Making Healthcare Safer III | Agency for Healthcare Research and Quality
     www.ahrq.gov/research/findings/making-healthcare-safer/mhs3/index.html
     August 01, 2024 - Harms such as adverse drug events, healthcare-associated infections (HAIs), falls, and obstetric adverse … Harms Due to Anticoagulants (PDF, 2 MB) Harms Due to Diabetic Agents (PDF, 1.6 MB) Reducing Adverse Drug

105. Glossary | Agency for Healthcare Research and Quality
     www.ahrq.gov/questions/resources/glossary.html
     November 01, 2020 - Antibiotic: A drug used to treat infections caused by bacteria and other microorganisms. … Food and Drug Administration (FDA). … After the patent runs out on a brand-name drug, companies can apply to the FDA to make a generic copy … of that drug. … Side Effect: An effect of a drug, chemical, or other medicine that is in addition to its intended effect

106. Part 2: Trends in Priorities of the Heckler Report—Care for Substance Use Disorders | Agency for Healthcare Research and Quality
     www.ahrq.gov/research/findings/nhqrdr/chartbooks/blackhealth/part2-subuse.html
     June 01, 2018 - Results from the 1983 single-room occupancy hotels study of drug abuse in New York City suggested that … Blacks had higher rates of drug use than Whites for marijuana, cocaine, heroin, and illicit methadone … drug use or an alcohol problem and who received such treatment at a specialty facility in the last 12 … Note: Treatment refers to treatment at a specialty facility, such as a drug and alcohol inpatient and … Overall Rate: In 2013, only 10.9% of people age 12 and over who needed treatment for illicit drug use

107. Final Progress Report: UIC Center for Education and Research on Therapeutics Tools for Optimizing Prescribing, Monitoring and Education (TOP-MED) (pdf file)
     www.ahrq.gov/sites/default/files/2024-01/lambert2-report.pdf
     January 01, 2024 - Revitalize the drug formulary as an evidence-based tool for directing drug therapy decisions. 2. … The inter-drug module compares the rate of an AE for an individual drug with a background Poisson prediction … The Investigational Drug Service developed a support service to assist with drug study blinding and … Our Investigational Drug Service team has developed a support service model to assist with study drug … Drug Safety, 34(7): 533-544.

108. Part 2: Trends in Priorities of the Heckler Report—Care for Substance Use Disorders | Agency for Healthcare Research and Quality
     www.ahrq.gov/research/findings/nhqrdr/2014chartbooks/hispanichealth/part2-sbuse.html
     May 01, 2018 - Results from the 1983 single-room occupancy hotels study of drug abuse in New York City suggest that … Hispanics have higher rates of drug use than Whites for marijuana, cocaine, heroin, and illicit methadone … the last 12 months Same No Change People age 12 and over who needed treatment for illicit drug … Note: Treatment refers to treatment at a specialty facility, such as a drug and alcohol inpatient and … Overall Rate: In 2012, only 10.8% of people age 12 and over who needed treatment for illicit drug use

109. Final Progress Report: Risk Analysis of Pediatric Chemotherapy Processes (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/research/findings/final-reports/14295%20Shenep-draft-1.pdf
     June 01, 2005 - Calculate the drug dosage. … Likewise, if a mistake is found after the drug is dispensed, the drug is returned to the pharmacy … Visually verify that the drug in the bag matches the drug indicated on the label and order (e.g., confirm … Once in the prep area, double check the drug and drug concentration against the label. … , sound-alike drug name) RPN score: 70 15.2 Drug supplies past their expiration date used in preparation

110. Optimizing Treatment Combinations in Individuals with Multiple Chronic Conditions (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/professionals/prevention-chronic-care/decision/mcc/gagne-r01grant.pdf
     November 30, 2015 - 06/01/14--11/30/15 Grant Number: R01 HS023122-01 Description The clinical consequences of most drug-drug … clinical outcomes related to DDIs in patients with depression and other chronic conditions requiring drug … Modify existing semi-automated programs for rapid drug-drug interactions (DDI) assessment in electronic

111. AHRQ Signals Intent To Fund Clinics To Improve Care for People With Long COVID | Agency for Healthcare Research and Quality
     www.ahrq.gov/news/newsletters/e-newsletter/852.html
     February 01, 2023 - Physicians Should Consider Potential Drug Interactions When Prescribing Colchicine . … The AOP study examined clinical outcomes associated with colchicine drug interactions using reports … Food and Drug Administration’s Adverse Event Reporting System from January 2004 through June 2020. … It found a total of 787 reports that pointed to an adverse event from a colchicine drug interaction. … Both studies emphasized that colchicine drug interactions can almost always be prevented through proper

112. Novel Role for Adiponectin-enhancing Drugs for Asthma in the Obese (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/professionals/prevention-chronic-care/decision/mcc/sood-r01grant.pdf
     January 31, 2016 - Potent adiponectin-enhancing drugs include the antidiabetic drug class of thiazolidinediones (TZD) and … antihypertensive drug class of angiotensin receptor blockers (ARB).

113. AHRQ Six Building Blocks: A Team-Based Approach to Improving Opioid Management in Primary Care | Agency for Healthcare Research and Quality
     www.ahrq.gov/patient-safety/settings/ambulatory/improve/six-building-blocks.html
     March 01, 2022 - Blocks: A Team-Based Approach to Improving Opioid Management in Primary Care Deaths from drug … support for the 6BBs program came from the Washington State Department of Health, National Institute on Drug

114. Technology for Improving Medication Monitoring in Nursing Homes (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety/vol4/Lapane.pdf
     March 09, 2005 - selection6–8 can lead to complications in drug therapy, often manifested as an adverse drug event ( … , whether the treatment includes an unsafe drug for the particular patient) … Are any conditions the result of drug therapy? … reaction Wrong drug; Dose too low Unnecessary drug therapy; Needs additional drug therapy … Incidence and preventability of adverse drug events in nursing homes.

115. Final Progress Report: Advancing Patient Safety Innovation in Rheumatology (ASPIRE) (pdf file)
     www.ahrq.gov/sites/default/files/2024-02/yazdany-report.pdf
     January 01, 2024 - Food and Drug Administration Adverse Event Reporting System (FAERS). … Expert Opin Drug Saf. 2017;16(7):761-767. 3. Bourgeois FT, Shannon MW, Valim C, Mandl KD. … Adverse drug events in the outpatient setting: an 11-year national analysis. … Pharmacoepidemiology and drug safety. 2010;19(9):901-910. 4. Perrillo RP, Martin P, Lok AS. … Food and Drug Administration and Federal Trade Commission.

116. A Patient Safety Program & Research Evaluation of U.S. Navy Pharmacy Refill Clinics (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety/vol1/Reige.pdf
     March 01, 2004 - The aim of this early program was improved monitoring of drug therapy, and patients with stable, drug … The program demonstrated that a pharmacist is capable of monitoring drug therapy. … This one case resulted in a drug-acquisition savings of $102.20 per year. … The resulting drug acquisition cost savings was $47.45 per year. … Percent of drug categories for Keflavik Pharmacy Refill Clinic Figure 4.

117. Antibiotic Stewardship Program (ASP) Development
     www.ahrq.gov/sites/default/files/wysiwyg/antibiotic-use/long-term-care/program-dev-slides.pptx
     June 01, 2021 - No monitoring for drug-drug interactions. No followup to narrow therapy. … No monitoring for drug-drug interactions. No followup to narrow therapy. … improvement The team chooses to focus on 2 post-prescriptive opportunities for improvement Monitor for drug-drug … No monitoring for drug-drug interactions. No followup to narrow therapy. … Developing a Program 14 Baseline Data Monitor for drug-drug interactions.

118. Final Progress Report: Show Your Work: Do Prescription Annotations Impact Near-miss Medication Errors? (pdf file)
     www.ahrq.gov/sites/default/files/2024-01/johnson-baughman-report.pdf
     January 01, 2024 - generating correct doses of prescriptions and medications; improving physician recognition of potential drug-drug … , drug- allergy, drug-food, or drug-indication reactions or contraindications; and improving compliance … FDB supports drug-allergy, drug-drug, drug-food, and drug-indication warnings as well as guidelines … Error-related callbacks Patient Instructions Contrary to Rx 15 2.98% Directions 55 10.91% Dosing 14 2.77% Drug-Drug … National Association of Chain Drug Stores; 1999. 18.

119. CHIPRA 233: Section 3, Table 2, FDA Pregnancy Category Rating (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-233-hrob-section-3-table-2.pdf
     August 08, 2018 - Food and Drug Administration Pregnancy Category Rating Pregnancy Category Explanation Category … are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug … investigational or marketing experience or studies in humans, but potential benefits may warrant use of the drug … reaction data from investigational or marketing experience, and the risks involved in use of the drug

120. Final Progress Report: Pharmacist Technology for Nursing Home Resident Safety (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/research/findings/final-reports/11835-Lapane-draft-1.pdf
     January 01, 2006 - Prospective drug regimen review: Current regulations require that the drug regimen of every nursing … The prevention of adverse drug events. ECPN 2005;June:26-32. Feinberg JL. … Approaches for optimisation of drug prescribing in elderly people. … Drug utilization in the US: 1986. … Incidence and preventability of adverse drug events in nursing homes.